Treatment of acute myeloid leukemia. - Wikidata - wikimedia - TriplyDB

Treatment of acute myeloid leukemia.

Treatment of acute myeloid leukemia.

http://www.wikidata.org/entity/Q41893399

about

Molecular prognostic factors in cytogenetically normal acute myeloid leukemia Randomized trial of two schedules of low-dose gemtuzumab ozogamicin as induction monotherapy for newly diagnosed acute myeloid leukaemia in older patients not considered candidates for intensive chemotherapy. A phase II study of the EORTC and GIMEMA Challenges in treating older patients with acute myeloid leukemia.Assessment of the consistency and robustness of results from a multicenter trial of remission maintenance therapy for acute myeloid leukemia.The tumor suppressive role of miRNA-370 by targeting FoxM1 in acute myeloid leukemia.A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia Increased anti-leukemic activity of decitabine via AR-42-induced upregulation of miR-29b: a novel epigenetic-targeting approach in acute myeloid leukemia.Myeloid leukemia with transdifferentiation plasticity developing from T-cell progenitors.Predictive performance of early warning scores in acute leukemia patients receiving induction chemotherapy.Antrodia camphorata induces G(1) cell-cycle arrest in human premyelocytic leukemia (HL-60) cells and suppresses tumor growth in athymic nude mice.miR-134 increases the antitumor effects of cytarabine by targeting Mnks in acute myeloid leukemia cells.

P2860

Q26998811-92FC8238-689D-43C8-B4DC-07FBE8BFF67F Q33828797-43EA9BB7-277C-4091-9FE0-A3A7E04B1DC2 Q33985549-9D143402-8CF3-47AE-A22D-5D6EC158B307 Q34797782-3513D75E-4509-4778-B6C7-BA0CE1F245DC Q36498517-AF7BEFE5-F1CA-4FA6-AE03-50027C267011 Q36926129-B586E83B-AE9F-4095-8D4A-33C9D137CD35 Q39239363-E6581C74-C5F1-45E7-87EF-E34653ADC3C8 Q39443070-D08DB047-8177-453A-88BA-A7DAEA448C24 Q47686033-6955F888-A9CD-47AC-8571-E105B030B968 Q54335034-5E4118D7-E05D-402B-9AB3-8550B3A7EE59 Q54988438-1DECC34F-5A48-4305-8218-2F28B2BAB518

P2860

Treatment of acute myeloid leukemia.

http://www.wikidata.org/entity/Q41893399

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Treatment of acute myeloid leukemia.

@en

type

label

Treatment of acute myeloid leukemia.

@en

prefLabel

Treatment of acute myeloid leukemia.

@en

P1433

Q41893399-3CCC551F-B2E4-41D8-AB3B-536CD84C8E3C

P1476

Q41893399-8500D7FF-175A-4228-B94B-29703CDE42ED

P2093

Q41893399-9D24070C-762A-4CD6-B3D1-A1A2EFB379B4

P2860

Q41893399-0AC7BA24-FD20-4B52-AFC9-E9CB427D59EE

Q41893399-104FCBF7-C1E9-4711-A375-CB02D86C1DF5

Q41893399-1E3AEE33-11A9-4CF4-9012-318D10ECF745

Q41893399-1E7731E5-4BC6-495D-AA96-7E1136A6217C

Q41893399-2044B126-B4F5-42EE-ABB6-FCEBB3506102

Q41893399-28979A65-1F0D-4D03-9C99-2E635FA47AA3

Q41893399-2AEA6B06-92E1-4547-9D9F-0265F768B576

Q41893399-2B2F0057-5C26-4836-B4FC-FE50CEC0093D

Q41893399-46272415-1855-4163-AB3D-26E251939316

Q41893399-4CC5BF06-4F8D-4B40-807B-5943C70580BA

P304

Q41893399-C7033E0A-AF32-4392-96CF-50B4CD17EEA3

P31

Q41893399-33187173-A4DB-4073-AA9B-B1131765B576

Q41893399-88408a52-d227-42e7-9e00-0605bfe97b8a

P356

Q41893399-B45EDFAB-ACA5-473B-AF77-E388AD45D6CB

P433

Q41893399-C7821B8C-6A7C-4CDB-B011-E7BC3FABF417

P478

Q41893399-4A0FCF6C-78B4-4ACF-B01C-240F34E3DD1B

P577

Q41893399-F79197B5-E67F-42E5-B89D-9C926534FE74

P698

Q41893399-AB906030-D3C9-4D98-989F-A06C24923E36

P932

Q41893399-9BD49B24-E9B3-49B4-823C-C67C9FD3D35C

P356

HAEMATOL.2008.001263

P1433

P1476

Treatment of acute myeloid leukemia.

@en

P2093

Elihu H Estey

http://www.w3.org/2001/XMLSchema#string

P2860

Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98B.

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study

Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties

Treatment of core-binding-factor in acute myelogenous leukemia with fludarabine, cytarabine, and granulocyte colony-stimulating factor results in improved event-free survival.

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial.

Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia.

Further analysis of trials with azacitidine in patients with myelodysplastic syndrome: studies 8421, 8921, and 9221 by the Cancer and Leukemia Group B.

Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?

Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients

P304

10-16

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3324/HAEMATOL.2008.001263

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19118375

http://www.w3.org/2001/XMLSchema#string

P932

2625419

http://www.w3.org/2001/XMLSchema#string